Nebenwirkungen · Bortezomib Accord
Bortezomib Accord 1 mg powder for solution for injection Bortezomib Accord 3.5 mg powder for solution for injection · Abschnitt 4.8 · PDF-Seite 52–53
HOS-133327 · Präparat HOS-097412
52 System Organ Class Incidence Adverse reaction Hepatobiliary Common Hepatotoxicity (inc liver disorder) disorders Uncommon Hepatic failure Skin and Very Common Hair disorder* subcutaneous Common Pruritus*, Dermatitis*, Rash* tissue disorders Musculoskeletal Common Muscle spasms*, Musculoskeletal pain*, Pain in extremity and connective tissue disorders Renal and urinary Common Urinary tract infection* disorders General disorders Very Common Pyrexia*, Fatigue, Asthenia and administration Common Oedema (inc peripheral), Chills, Injection site reaction*, site conditions Malaise* Investigations Common Hyperbilirubinaemia*, Protein analyses abnormal*, Weight decreased, Weight increased * Grouping of more than one MedDRA preferred term.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-25T15:00:00Z · SHA-256 95954b33292c291c1f0b9499f65ea0d9efd1266892e12a142f48541fdf5605bb · Passage a03d27d60e80cf0f80b909dc8a6fb6e76b5b9138301b21a438fd9dea33b4f8db · Zeichen 24640–25563 im Abschnitt